HIGHOutside partyCustomer
68.8%
top ten customers
“10-K Item 1A: 'Our top ten customers represented approximately 68.8%, 68.1%, and 59.3% of our total net sales in 2025, 2024, and 2023, respectively.'”
UFPT · Concentration risk · 10-K extracted
UFP Technologies (UFPT) concentration risks
Updated
The most significant concentration UFP Technologies discloses is top ten customers at 68.8%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: UFP Technologies’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 4 disclosed concentrations
HIGH1
MEDIUM1
LOW2
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMOutside partySupplier
cross-linked and technical polyurethane foam and TPU suppliers
“10-K Item 1: 'the Company relies upon a limited number of suppliers for cross-linked and technical polyurethane foams, and TPU'”
LOWOutside partyCustomer
24.3%
Intuitive Surgical SARL
“10-K Item 1A: 'Two customers (Intuitive Surgical SARL and Stryker) comprised approximately 24.3% and 21.5%, respectively, of our net sales for the year ended December 31, 2025'”
LOWOutside partyCustomer
21.5%
Stryker
“10-K Item 1A: 'Two customers (Intuitive Surgical SARL and Stryker) comprised approximately 24.3% and 21.5%, respectively, of our net sales for the year ended December 31, 2025'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-07-06UFP Technologies' disclosed concentration is heavily customer-weighted. The top ten customers represented approximately 68.8% of total net sales in 2025, up from 68.1% and 59.3% in the two prior years, a share disclosed at a high level. Within that group, two customers stand out individually: Intuitive Surgical SARL comprised approximately 24.3% of net sales for the year ended December 31, 2025, and Stryker comprised approximately 21.5% over the same period — both disclosed at a low share level individually. On the supply side, the company also relies upon a limited number of suppliers for cross-linked and technical polyurethane foams and TPU, a dependency-type exposure disclosed at a medium share level. Together, these exposures paint a picture of a business whose growth is closely tied to a small number of large medical-device customers: the top-ten share has risen over three years, and Intuitive Surgical and Stryker individually represent two of the largest single contributors within that group. Because both named customers are individually dependency-type, the loss of either would be a meaningful, idiosyncratic event, while the supplier concentration adds a secondary, input-side risk that could compress margins independently of customer demand.
For the engine’s reasoning on UFPT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| AVNS | Avanos Medical, Inc. | 2 | 0 | 1 | 3 |
| UFPT● | UFP Technologies, Inc. | 1 | 1 | 2 | 4 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.